Viewing nowPioglitazone Hydrochloride Tablets 30mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Korea Hutex Pharmaceutical Co., Ltd.

MFDS item code 201708138 · Approved 2017.11.29 · Insurance code 649103750
Improvement of glycemic control in type 2 diabetes mellitus
This medication is administered as an adjunct to diet and exercise in order to help control blood glucose in patients with type 2 diabetes. It can be used alone, and if there is no improvement in blood glucose levels after using other oral hypoglycemic agents, it can be prescribed in combination with sulfonylureas, metformin, or insulin. Additionally, it is important for patients with type 2 diabetes to engage in nutritional counseling, weight loss, and regular exercise to continuously improve the effectiveness of both initial treatment and medication therapy. This medication is used to effectively improve blood glucose control in patients with type 2 diabetes.
This product is administered orally once daily, with or without food. 1. Monotherapy This product may be initiated at 15 mg once daily as monotherapy in patients whose blood glucose is not adequately controlled with diet and exercise. If the initial dose is not sufficiently effective, it may be increased to 30 mg once daily. 2. Combination therapy - When used in combination with a sulfonylurea, the initial dose is 15 mg once daily - When used in combination with metformin, the initial dose is 15 mg once daily - When used in combination with insulin, the dose is 15 mg once daily The maximum recommended dose is 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use in this age group.
This medication is used for the treatment of type 2 diabetes. During the course of treatment, attention should be paid to heart function. In particular, congestive heart failure may worsen, so if symptoms such as sudden weight gain, shortness of breath, or leg swelling occur, medical advice should be sought immediately. Patients with heart failure or a history of heart failure should not take this medication. This medication can cause fluid retention, potentially leading to swelling, so any symptoms of swelling should be reported to a healthcare provider. Furthermore, this medication should not be administered to patients with bladder cancer or a history of bladder cancer. If symptoms such as pain during urination, hematuria, or urinary urgency occur, medical attention must be sought immediately. Patients with poor liver function or severely impaired kidney function should also avoid this medication. Women who are pregnant or may become pregnant should consult a physician before taking this medication, and premenopausal women are advised to use appropriate contraception as the risk of pregnancy may increase while taking this medication. There is an increased risk of hypoglycemia when this medication is taken with other diabetes medications, so careful monitoring for hypoglycemic symptoms is essential, and adjustments to the doses of other medications may be necessary. Regular monitoring of blood glucose levels, liver function tests, etc., should be performed while taking this medication, and any symptoms indicating weight gain, swelling, or liver damage (fatigue, loss of appetite, abdominal pain, jaundice, etc.) should be reported to a physician immediately. Elderly patients or those with impaired liver or kidney function should exercise extra caution when taking this medication and should follow their physician’s instructions. In cases of overdose, no specific symptoms may be present, but if overdose is suspected, immediate medical attention should be sought. The safety and efficacy of this medication have not been established in children, so it is not recommended for patients under the age of 18. Store this medication out of the reach of children and keep it in the original container. During treatment, it is essential to adhere strictly to the prescribed method and dosage, and in case of a missed dose, avoid taking double the dose at the next intake.
Congestive heart failure, excessive and rapid weight changes, dyspnea, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal distention, weight gain, hypoglycemia, urinary tract infection, lumbar pain, dizziness, diarrhea, increased serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular predisposition, hospitalization due to worsening congestive heart failure, emergency room visit due to congestive heart failure, adverse cardiovascular events, dizziness, increased blood sugar, elevated ALT/AST, loss of appetite, constipation, upper abdominal pain, chest discomfort, fatigue, weakness, dyspepsia, nausea, dyspnea, itching, chest unease, tremors, chills, gastrointestinal disease, abdominal pain, epigastric discomfort, numbness, muscle stiffness, discomfort in the head, increased liver enzymes, worsening liver disease, urticaria, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, abdominal pain, heart failure, adverse reactions related to edema, liver failure, macular edema, fracture
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that is well protected from light and air, and a humid environment should be avoided. The storage temperature should be maintained between 15 and 30 degrees Celsius.
White round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Korea Hutex Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.